• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物合成纳米气泡介导的Cdh2基因CRISPR/Cas9编辑抑制乳腺癌转移。

Biosynthetic Nanobubble-Mediated CRISPR/Cas9 Gene Editing of Cdh2 Inhibits Breast Cancer Metastasis.

作者信息

Gao Ruru, Luo Qiong, Li Yang, Song Liming, Cai Junnan Stephen, Xiong Ying, Yan Fei, Liu Jianhua

机构信息

Department of Medical Ultrasound, The Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou 510180, China.

Department of Gastrointestinal Surgery, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University), Shenzhen 518020, China.

出版信息

Pharmaceutics. 2022 Jun 30;14(7):1382. doi: 10.3390/pharmaceutics14071382.

DOI:10.3390/pharmaceutics14071382
PMID:35890278
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9319454/
Abstract

The epithelial-mesenchymal transition (EMT), a process in which epithelial cells undergo a series of biochemical changes to acquire a mesenchymal phenotype, has been linked to tumor metastasis. Here, we present a novel strategy for knocking out the EMT-related Cdh2 gene, which encodes N-cadherin through CRISPR/Cas9-mediated gene editing by an ultrasound combined with biosynthetic nanobubbles (Gas Vesicles, GVs). Polyethyleneimine were employed as a gene delivery vector to deliver sgRNA into 4T1 cells that stably express the Cas9 protein, resulting in the stable Cdh2 gene- knockout cell lines. The Western blotting assay confirmed the absence of an N-cadherin protein in these Cdh2 gene-knockout 4T1 cell lines. Significantly reduced tumor cell migration was observed in the Cdh2 gene-knockout 4T1 cells in comparison with the wild-type cells. Our study demonstrated that an ultrasound combined with GVs could effectively mediate CRISPR/Cas9 gene editing of a Cdh2 gene to inhibit tumor invasion and metastasis.

摘要

上皮-间质转化(EMT)是上皮细胞经历一系列生化变化以获得间质表型的过程,与肿瘤转移有关。在此,我们提出了一种通过超声联合生物合成纳米气泡(气体囊泡,GVs)进行CRISPR/Cas9介导的基因编辑来敲除与EMT相关的Cdh2基因(该基因编码N-钙黏蛋白)的新策略。使用聚乙烯亚胺作为基因递送载体,将sgRNA递送至稳定表达Cas9蛋白的4T1细胞中,从而获得稳定的Cdh2基因敲除细胞系。蛋白质免疫印迹分析证实这些Cdh2基因敲除的4T1细胞系中不存在N-钙黏蛋白。与野生型细胞相比,在Cdh2基因敲除的4T1细胞中观察到肿瘤细胞迁移显著减少。我们的研究表明,超声联合GVs可有效介导Cdh2基因的CRISPR/Cas9基因编辑,以抑制肿瘤侵袭和转移。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a587/9319454/21ff157335d3/pharmaceutics-14-01382-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a587/9319454/4ca9194b83f0/pharmaceutics-14-01382-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a587/9319454/b9e058b83b1f/pharmaceutics-14-01382-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a587/9319454/8510069cdb84/pharmaceutics-14-01382-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a587/9319454/e54a837cc81f/pharmaceutics-14-01382-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a587/9319454/d519ed8f51c8/pharmaceutics-14-01382-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a587/9319454/21ff157335d3/pharmaceutics-14-01382-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a587/9319454/4ca9194b83f0/pharmaceutics-14-01382-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a587/9319454/b9e058b83b1f/pharmaceutics-14-01382-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a587/9319454/8510069cdb84/pharmaceutics-14-01382-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a587/9319454/e54a837cc81f/pharmaceutics-14-01382-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a587/9319454/d519ed8f51c8/pharmaceutics-14-01382-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a587/9319454/21ff157335d3/pharmaceutics-14-01382-g006.jpg

相似文献

1
Biosynthetic Nanobubble-Mediated CRISPR/Cas9 Gene Editing of Cdh2 Inhibits Breast Cancer Metastasis.生物合成纳米气泡介导的Cdh2基因CRISPR/Cas9编辑抑制乳腺癌转移。
Pharmaceutics. 2022 Jun 30;14(7):1382. doi: 10.3390/pharmaceutics14071382.
2
Lentiviral CRISPR/Cas9 vector mediated miR-21 gene editing inhibits the epithelial to mesenchymal transition in ovarian cancer cells.慢病毒CRISPR/Cas9载体介导的miR-21基因编辑抑制卵巢癌细胞的上皮-间质转化。
J Cancer. 2017 Jan 1;8(1):57-64. doi: 10.7150/jca.16723. eCollection 2017.
3
Knockout of MTF1 Inhibits the Epithelial to Mesenchymal Transition in Ovarian Cancer Cells.MTF1基因敲除抑制卵巢癌细胞的上皮-间质转化
J Cancer. 2018 Nov 11;9(24):4578-4585. doi: 10.7150/jca.28040. eCollection 2018.
4
Lentiviral CRISPR/Cas9 nickase vector mediated BIRC5 editing inhibits epithelial to mesenchymal transition in ovarian cancer cells.慢病毒CRISPR/Cas9切口酶载体介导的BIRC5编辑抑制卵巢癌细胞的上皮-间质转化
Oncotarget. 2017 Oct 17;8(55):94666-94680. doi: 10.18632/oncotarget.21863. eCollection 2017 Nov 7.
5
MicroRNA-124 inhibits canine mammary carcinoma cell proliferation, migration and invasion by targeting CDH2.MicroRNA-124 通过靶向 CDH2 抑制犬乳腺肿瘤细胞的增殖、迁移和侵袭。
Res Vet Sci. 2022 Sep;146:5-14. doi: 10.1016/j.rvsc.2022.03.004. Epub 2022 Mar 8.
6
Scaffold-mediated non-viral delivery platform for CRISPR/Cas9-based genome editing.支架介导的非病毒递送平台用于基于 CRISPR/Cas9 的基因组编辑。
Acta Biomater. 2019 May;90:60-70. doi: 10.1016/j.actbio.2019.04.020. Epub 2019 Apr 9.
7
TGF-β-activated SMAD3/4 complex transcriptionally upregulates N-cadherin expression in non-small cell lung cancer.转化生长因子-β激活的SMAD3/4复合物在非小细胞肺癌中转录上调N-钙黏蛋白的表达。
Lung Cancer. 2015 Mar;87(3):249-57. doi: 10.1016/j.lungcan.2014.12.015. Epub 2015 Jan 5.
8
CRISPR-Cas9 mediated CD133 knockout inhibits colon cancer invasion through reduced epithelial-mesenchymal transition.CRISPR-Cas9 介导的 CD133 基因敲除通过降低上皮-间充质转化抑制结肠癌细胞侵袭。
PLoS One. 2019 Aug 8;14(8):e0220860. doi: 10.1371/journal.pone.0220860. eCollection 2019.
9
Ribozyme-mediated CRISPR/Cas9 gene editing in pyrethrum (Tanacetum cinerariifolium) hairy roots using a RNA polymerase II-dependent promoter.使用RNA聚合酶II依赖性启动子在除虫菊(Tanacetum cinerariifolium)毛状根中进行核酶介导的CRISPR/Cas9基因编辑
Plant Methods. 2022 Mar 16;18(1):32. doi: 10.1186/s13007-022-00863-5.
10
Peptide and Aptamer Decorated Delivery System for Targeting Delivery of Cas9/sgRNA Plasmid To Mediate Antitumor Genome Editing.肽和适体修饰的递药系统,用于靶向递送 Cas9/sgRNA 质粒以介导抗肿瘤基因组编辑。
ACS Appl Mater Interfaces. 2019 Jul 10;11(27):23870-23879. doi: 10.1021/acsami.9b05772. Epub 2019 Jul 1.

引用本文的文献

1
Visibly acoustic delivery of IR808 into tumor via gas vesicles enhances photothermal therapy efficacy against tumor.通过气体囊泡将IR808可视声学递送至肿瘤内可增强对肿瘤的光热治疗效果。
Ultrason Sonochem. 2025 Aug;119:107398. doi: 10.1016/j.ultsonch.2025.107398. Epub 2025 May 24.
2
Advanced Strategies for Ultrasound Control and Applications in Sonogenetics and Gas Vesicle-Based Technologies: A Review.超声控制的先进策略及其在声遗传学和基于气体囊泡技术中的应用:综述
Int J Nanomedicine. 2025 May 22;20:6533-6549. doi: 10.2147/IJN.S507322. eCollection 2025.
3
Emerging Gene-editing nano-therapeutics for Cancer.

本文引用的文献

1
Polyethyleneimine-anchored liposomes as scavengers for improving the efficiency of protein-bound uremic toxin clearance during dialysis.
J Biomed Mater Res A. 2022 Apr;110(4):976-983. doi: 10.1002/jbm.a.37346. Epub 2021 Dec 15.
2
Downregulation of NPTX1 induces cell cycle progression through Wnt/β-catenin signaling in breast cancer.NPTX1的下调通过Wnt/β-连环蛋白信号通路诱导乳腺癌细胞周期进程。
J Biol Regul Homeost Agents. 2021 May-Jun;35(3):1177-1183. doi: 10.23812/21-82-L.
3
New biomarker for lung cancer - focus on circSETD3.用于肺癌的新型生物标志物——聚焦环状 RNA SETD3。
新兴的用于癌症治疗的基因编辑纳米疗法
Heliyon. 2024 Oct 20;10(21):e39323. doi: 10.1016/j.heliyon.2024.e39323. eCollection 2024 Nov 15.
4
Applications of CRISPR Technology to Breast Cancer and Triple Negative Breast Cancer Research.CRISPR技术在乳腺癌和三阴性乳腺癌研究中的应用。
Cancers (Basel). 2023 Sep 1;15(17):4364. doi: 10.3390/cancers15174364.
5
Nanoparticles in Medicine: Current Status in Cancer Treatment.医学纳米粒子:癌症治疗的当前现状。
Int J Mol Sci. 2023 Aug 15;24(16):12827. doi: 10.3390/ijms241612827.
6
The CRISPR/Cas9 System Delivered by Extracellular Vesicles.由细胞外囊泡递送的CRISPR/Cas9系统。
Pharmaceutics. 2023 Mar 18;15(3):984. doi: 10.3390/pharmaceutics15030984.
J Biol Regul Homeost Agents. 2021 Mar-Apr;35(2):583-591. doi: 10.23812/20-664-L.
4
Cancer Statistics, 2021.癌症统计数据,2021.
CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12.
5
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia.CRISPR-Cas9 基因编辑治疗镰状细胞病和 β-地中海贫血。
N Engl J Med. 2021 Jan 21;384(3):252-260. doi: 10.1056/NEJMoa2031054. Epub 2020 Dec 5.
6
CRISPR based editing of SIV proviral DNA in ART treated non-human primates.基于 CRISPR 的 SIV 前病毒 DNA 在接受 ART 治疗的非人类灵长类动物中的编辑。
Nat Commun. 2020 Nov 27;11(1):6065. doi: 10.1038/s41467-020-19821-7.
7
Cancer burden and trends in China: A review and comparison with Japan and South Korea.中国的癌症负担与趋势:一项综述及与日本和韩国的比较。
Chin J Cancer Res. 2020 Apr;32(2):129-139. doi: 10.21147/j.issn.1000-9604.2020.02.01.
8
Applications of Micro/Nanotechnology in Ultrasound-based Drug Delivery and Therapy for Tumor.微纳技术在基于超声的肿瘤药物输送和治疗中的应用。
Curr Med Chem. 2021;28(3):525-547. doi: 10.2174/0929867327666200212100257.
9
Somatic gene editing ameliorates skeletal and cardiac muscle failure in pig and human models of Duchenne muscular dystrophy.体细胞基因编辑改善了杜氏肌营养不良症猪和人类模型的骨骼肌和心肌衰竭。
Nat Med. 2020 Feb;26(2):207-214. doi: 10.1038/s41591-019-0738-2. Epub 2020 Jan 27.
10
CRISPR-Edited Stem Cells in a Patient with HIV and Acute Lymphocytic Leukemia.经 CRISPR 编辑的干细胞在一名 HIV 合并急性淋巴细胞白血病患者中的应用。
N Engl J Med. 2019 Sep 26;381(13):1240-1247. doi: 10.1056/NEJMoa1817426. Epub 2019 Sep 11.